Novartis Pays $678M For Sham Speaker Programs, Drug Co-Pay Kickbacks
Swiss drug maker Novartis Pharmaceuticals Corp. will pay $678 million to settle a false claims lawsuit alleging that it paid kickbacks through sham speaker programs and three drug co-pay charities, according...To view the full article, register now.
Already a subscriber? Click here to view full article